Prolyl endopeptidase inhibitory activity of unsaturated fatty acids

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 4, 2006, Pages 1238-1242

  Park, Yoon Seok ^a   Jang, Hyun Jung ^a   Lee, Kyung Ho ^a   Hahn, Tae Ryong ^a   Paik, Young Sook ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Antiamnestic; Arachidonic acid; DHA; EPA; Linoleic acid; Oleic acid; Prolyl endopeptidase inhibitor

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OLEIC ACID; PROLYL ENDOPEPTIDASE; PROTEINASE INHIBITOR; SERINE PROTEINASE; UNSATURATED FATTY ACID;

ALZHEIMER DISEASE; ARTICLE; ENZYMOLOGY; HUMAN;

ALZHEIMER DISEASE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; HUMANS; LINOLEIC ACID; OLEIC ACID; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES;

EID: 33644859468     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf052521h     Document Type: Article

References (25)

1. Calvaresi, E.; Bryan, J. B Vitamins, cognition, and aging: A review. J. Gerontol. 2001, 56B, 327-339.
2. Engelhart, M. J.; Geerlings, M. I.; Ruitenberg, A.; van Swieten J. C.; Hofman, A.; Witteman, J. C.; Breteler, M. M. Dietary intake of antioxidants and risk of Alzheimer disease. J. Am. Med. Assoc. 2002, 287, 3223-3229.
3. Markesbery, W. R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 1997, 23, 134-147.
4. Morris, M. C.; Evans, D. A.; Bienias, J. L.; Tangney, C. C.; Bennett, D. A.; Aggarwal, N.; Schneider, J.; Wilson, R. S. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 2003, 60, 194-200.
5. Solfrizzi, V.; Panza, F.; Torres, F.; Mastroianni, F.; Del Parigi, A.; Venezia, A.; Capurso, A. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 1999, 52, 1563-1569.
6. Kalmijin, S.; van Boxtel, M. P. J.; Ocke, M.; Verschuren, W. M. M.; Kromhout, D.; Launer, L. J. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 62, 275-280.
7. Morris, M. C.; Evans, D. A.; Bienias, J. L.; Tangney, C. C.; Wilson, R. S. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 2004, 62, 1573-1579.
8. Panza, F.; Solfrizzi, V.; Colacicco, A. M.; D'Introno, A.; Capurso, C.; Torres, F.; Del Parigi, A.; Capurso, S.; Capurso, A. Mediterranean diet and cognitive decline. Public Health Nutr. 2004, 7, 959-963.
9. Barberger-Gateau, P.; Letenneur, L.; Deschamps, V.; Peres, K.; Dartigues, J.-F.; Renaud, S. Fish, meat, and risk of dementia: Cohort study. B. M. J. 2002, 325, 932-933.
10. Cunningham, D. F.; O'Connor, B. Proline specific peptidase. Biochim. Biophys. Acta 1997, 1343, 160-186.
11. Walter, R.; Shlank, H.; Glass, J. D.; Schwartz, I. L.; Kerenyi, T. D. Leucylglycinamide released from oxytocin by human uterine enzyme. Science 1971, 173, 827-829.
12. Kalwant, S.; Porter, A. G. Purification and characterization of human brain prolyl endopeptidase. Biochem. J. 1991, 276, 237-244.
13. Odaka, C.; Mizuochi, T.; Shirasawa, T.; Morain, P.; Checler, F. Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS Lett. 2002, 512, 163-167.
14. Aoyagi, T.; Wada, T.; Nagai, M.; Kojima, F.; Harada, S.; Takeuchi, T.; Takahashi, H.; Hirokawa, K.; Tsumita, T. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia 1991, 46, 94-97.
15. Polgar, L. Structure-function of prolyl ologopeptidase and its role in neurological disorders. Curr. Med. Chem. 2002, 2, 251-257.
16. Haag, M. Essential fatty acids and the brain. Can. J. Psychiatry 2003, 48, 195-203.
17. McCann, J. C.; Ames, B. N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005, 82, 281-295.
18. Yoshimoto, T.; Walter, R.; Tsuru, D. Proline-specific endopeptidase from Flavobacterium. J. Biol. Chem. 1980, 255, 4786-4792.
19. Lee, J.-H.; Lee, S.-Y.; Lee, K.-S.; Jang, H.-J.; Lee, K.-H.; Hahn, T.-R.; Paik, Y.-S. Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba. Planta Med. 2004, 70, 1228-1230.
20. Jang, H.-J.; Paik, Y.-S. Prolyl endopeptidase inhibitory activity of omega-3 polyunsaturated fatty acids. Agric. Chem. Biotechnol. 2004, 47, 178-180.
21. Yehuda, S.; Rabinovitz, S.; Carraso, R. L.; Mostofsky, D. I. Essential fatty acid preparation (SR-3) improves Alzheimer's patients' quality of life. Int. J. Neurosci. 1996, 87, 141-149.
22. Yehuda, S.; Rabinovitz, S.; Mostofsky, D. I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 1999, 56, 565-570.
23. Sultanova, N.; Makhmoor, T.; Yasin, A.; Abilov, Z. A.; Omurkamzinova, V. B.; Atta-ur-Rahman; Choudhary, M. I. Isotamarixen - A new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida. Planta Med. 2004, 70, 65-67.
24. Kimura, K.; Kawaguchi, N.; Yoshihama, M.; Kawanishi, G. Staurosporine, a prolyl endopeptidse inhibitor. Agric. Biol. Chem. 1990, 54, 3021-3022.
25. Song, K.-S.; Raskin, I. A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex. J. Nat. Prod. 2002, 65, 76-78.